WEBULL
News
WXIBF
4.500
NaN%
--
Weekly Report: what happened at WXIBF last week (1222-1226)?
Weekly Report · 12/29/2025 09:16
Weekly Report: what happened at WXIBF last week (1215-1219)?
Weekly Report · 12/22/2025 09:16
Weekly Report: what happened at WXIBF last week (1208-1212)?
Weekly Report · 12/15/2025 09:17
Weekly Report: what happened at WXIBF last week (1201-1205)?
Weekly Report · 12/08/2025 09:17
WuXi Biologics Signs MoU With Qatar Free Zones Authority To Set Up Middle East CRDMO Center
NASDAQ · 12/02/2025 05:39
Weekly Report: what happened at WXIBF last week (1124-1128)?
Weekly Report · 12/01/2025 09:16
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 11/25/2025 00:20
Weekly Report: what happened at WXIBF last week (1117-1121)?
Weekly Report · 11/24/2025 09:17
Weekly Report: what happened at WXIBF last week (1110-1114)?
Weekly Report · 11/17/2025 09:17
Weekly Report: what happened at WXIBF last week (1103-1107)?
Weekly Report · 11/10/2025 09:16
Weekly Report: what happened at WXIBF last week (1027-1031)?
Weekly Report · 11/03/2025 09:16
Weekly Report: what happened at WXIBF last week (1020-1024)?
Weekly Report · 10/27/2025 09:17
Weekly Report: what happened at WXIBF last week (1013-1017)?
Weekly Report · 10/20/2025 09:17
Goldman Sachs Keeps Their Hold Rating on Wuxi Biologics (Cayman) (WXIBF)
TipRanks · 10/17/2025 11:07
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Wuxi Biologics (Cayman) (OtherWXIBF) and Avalo Therapeutics (AVTX)
TipRanks · 10/17/2025 11:00
Weekly Report: what happened at WXIBF last week (1006-1010)?
Weekly Report · 10/13/2025 09:17
Weekly Report: what happened at WXIBF last week (0929-1003)?
Weekly Report · 10/06/2025 09:16
Weekly Report: what happened at WXIBF last week (0922-0926)?
Weekly Report · 09/29/2025 09:17
HSBC Sticks to Their Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
TipRanks · 09/27/2025 10:25
Weekly Report: what happened at WXIBF last week (0915-0919)?
Weekly Report · 09/22/2025 09:17
More
Webull provides a variety of real-time WXIBF stock news. You can receive the latest news about Wuxi Bio through multiple platforms. This information may help you make smarter investment decisions.
About WXIBF
WuXi Biologics (Cayman) Inc is an investment holding company principally engaged in the provision of end-to-end solutions and services for biologics discovery, development and manufacturing to customers involving in biologics industry. The Company mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The Company mainly conducts its business in the domestic and overseas markets.